⏳ Fetching live dividend data...
Home › Calculator › LIAN Dividend Calculator 2026
LianBio · NASDAQ
Price: $0.32 · Annual div: $9.55/share · Frequency: annual · Payout ratio: N/A · Ex-div: 2025-06-30
LIAN (LianBio) has a dividend yield of 2993.73%, based on an annual dividend of $9.55 per share and a price of $0.32. Over the last 12 months it paid $0.0000 per share — a trailing yield of 0.00%. Dividends are paid annual.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2025-06-30Latest | — | $0.4300 | 116.22% | $0.37 |
| 2024-03-15 | — | $4.7500 | 195.70% | $4.88 |
| 2024-02-26 | 2024-03-14 | $4.8000 | 114.83% | $4.18 |
LianBio is a biopharmaceutical firm dedicated to advancing and commercializing medical treatments for a broad spectrum of conditions, encompassing cardiovascular, oncological, respiratory, ophthalmic, and inflammatory diseases. Its primary operational focus is in China and other Asian nations. The company's development pipeline features several investigational therapies: mavacamten, aimed at addressing obstructive and non-obstructive hypertrophic cardiomyopathy, as well as heart failure with preserved ejection fraction; TP-03, for the treatment of Demodex blepharitis; NBTXR3, targeting head and neck squamous cell carcinoma and other solid tumors; Infigratinib, for first-line and second-line cholangiocarcinoma and gastric cancers; BBP-398, also for solid tumors; Omilancor and NX-13, both indicated for ulcerative colitis (with Omilancor additionally for Crohn's disease); LYR-210, for chronic rhinosinusitis; and Sisunatovir, under investigation for respiratory syncytial virus. To further its drug candidates, LianBio has established strategic alliances, including a collaboration with Tarsus Pharmaceuticals, Inc. for the development and commercialization of TP-03, an eye solution for Demodex blepharitis. They also partner with Nanobiotix S.A. for NBTXR3, a radioenhancer designed to be directly administered into malignant tumors before standard radiation therapy. The company was founded in 2019 and is headquartered in Princeton, New Jersey.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LIAN position with:
Real after-tax yield depends on where you live and how you hold LIAN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2993.73% | 2990.93% | $299,373 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2544.67% | 2541.87% | $254,467 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2394.98% | 2392.18% | $239,498 / yr |
| 🇬🇧 UK ISA | 0% | 2993.73% | 2990.93% | $299,373 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2731.78% | 2728.98% | $273,178 / yr |
| 🇨🇦 TFSA | 0% | 2993.73% | 2990.93% | $299,373 / yr |
| 🇨🇦 CA Taxable | 25% | 2245.30% | 2242.50% | $224,530 / yr |
| 🇦🇺 Super (pension) | 15% | 2544.67% | 2541.87% | $254,467 / yr |
| 🇦🇺 AU Taxable | 30% | 2095.61% | 2092.81% | $209,561 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2204.13% | 2201.33% | $220,413 / yr |
| 🇫🇷 FR Taxable | 30% | 2095.61% | 2092.81% | $209,561 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $9.55/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
LIAN pays quarterly — 4 times per year. Ex-div: 2025-06-30.
How LIAN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LIAN sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare LIAN with peers: LIAN vs ALLK · LIAN vs ANGN · LIAN vs ANPC
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LIAN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
LianBio (LIAN) is currently trading at $0.32, 9% below its 52-week high. The current dividend yield is 2993.73% based on an annual payout of $9.55 per share.
LianBio (LIAN) is a healthcare stock currently trading at $0.32 with a dividend yield of 2993.73%. It pays an annual dividend of $9.55 per share.
Auto-generated from live market data. For educational purposes only — not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.
At a 2993.73% yield, reinvesting every payout is not a realistic long-term assumption — payouts this high rarely last and the share price usually falls as they are paid, so we don't model DRIP growth for LIAN.
LIAN (LianBio) has a dividend yield of 2993.73%, based on an annual dividend of $9.55 per share and a price of $0.32. Over the last 12 months it paid $0.0000 per share — a trailing yield of 0.00%. Dividends are paid annual.
$10,000 in LIAN at a 2993.73% yield pays about $299,373 a year ($24,948 a month) before taxes. Payouts this high rarely last — don't count on this income continuing at today's rate.
At a 2993.73% yield, reinvesting every payout is not a realistic long-term assumption — payouts this high rarely last and the share price usually falls as they are paid, so we don't model DRIP growth for LIAN.
Enter your starting amount, monthly contribution and time horizon in the LIAN DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
LIAN's next ex-dividend date has not been announced yet; the most recent one was 2025-06-30. LIAN pays dividends annual. Buy before the ex-dividend date to receive the next payment.
LIAN's dividend changed -100.0% over the last year. It has less than five years of dividend history in our data, so there is no five-year growth rate yet.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever